Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2021

01-08-2021 | Correction

Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome

Authors: Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Hiroto Yanagisawa, Toshio Kitawaki, Kenji Nara, Masao Hagihara, Hiroshi Yamamoto, Masakuni Tanimizu, Chikako Kato, Tomoki Origuchi, Kazutaka Sunami, Yoshitaka Sunami, Taro Masunari, Nobuhiko Nakamura, Masanori Kobayashi, Keiko Yamagami, Katsuhiro Miura, Kazue Takai, Sadao Aoki, Norifumi Tsukamoto, Yasufumi Masaki

Published in: International Journal of Hematology | Issue 2/2021

Login to get access

Excerpt

In the original publication of the article, the abstract was wrongly published with grammatical errors. The correct abstract is given below: …
Metadata
Title
Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome
Authors
Hiroshi Kawabata
Shino Fujimoto
Tomoyuki Sakai
Hiroto Yanagisawa
Toshio Kitawaki
Kenji Nara
Masao Hagihara
Hiroshi Yamamoto
Masakuni Tanimizu
Chikako Kato
Tomoki Origuchi
Kazutaka Sunami
Yoshitaka Sunami
Taro Masunari
Nobuhiko Nakamura
Masanori Kobayashi
Keiko Yamagami
Katsuhiro Miura
Kazue Takai
Sadao Aoki
Norifumi Tsukamoto
Yasufumi Masaki
Publication date
01-08-2021
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 2/2021
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-021-03170-2

Other articles of this Issue 2/2021

International Journal of Hematology 2/2021 Go to the issue

Case Report

ETV6-related thrombocytopenia associated with a transient decrease in von Willebrand factor

Original Article

Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute

Original Article

Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids

Original Article

Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation

Original Article

Circulatory miR-155 correlation with platelet and neutrophil recovery after autologous hematopoietic stem cell transplantation, a multivariate analysis

Original Article

Patient’s age and d-dimer levels predict the prognosis in patients with TAFRO syndrome
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits